Multiple Sclerosis Journal· 2020Q1
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
- 2,562citations
- Q1SCImago
- 2020year
Short summary
The global prevalence of multiple sclerosis (MS) has increased since 2013, with an estimated 2.8 million people now living with the condition worldwide.
AI-generated from the title and abstract; the full text is not read.
Key points
- Global MS prevalence has risen to an estimated 2.8 million people (35.9 per 100,000).
- Prevalence has increased in every world region since 2013.
- Females are twice as likely as males to live with MS.
- Mean age of diagnosis is 32 years, with a pooled incidence rate of 2.1 per 100,000 persons/year across 75 countries.
- Significant gaps in epidemiological data collection remain worldwide.
AI-generated from the title and abstract; the full text is not read.
Abstract
BACKGROUND: High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people with multiple sclerosis (MS) and support advocacy efforts. OBJECTIVES: The Atlas of MS is an open-source global compendium of data regarding the epidemiology of MS and the availability of resources for people with MS reported at country, regional and global levels. METHODS: Country representatives reported epidemiologic data and their sources via survey between September 2019 and March 2020, covering prevalence and incidence in males, females and children, and age and MS type at diagnosis. Regional analyses and comparisons with 2013 data were conducted. RESULTS: A total of 2.8 million people are estimated to live with MS worldwide (35.9 per 100,000 population). MS prevalence has increased in every world region since 2013 but gaps in prevalence estimates persist. The pooled incidence rate across 75 reporting countries is 2.1 per 100,000 persons/year, and the mean age of diagnosis is 32 years. Females are twice as likely to live with MS as males. CONCLUSIONS: The global prevalence of MS has risen since 2013, but good surveillance data is not universal. Action is needed by multiple stakeholders to close knowledge gaps.
The authors' abstract, as published at the source. Multiple Sclerosis Journal, 2020 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pathology and Forensic Medicine
Pathology and Forensic MedicineMedicine